Search research articles
Contact Us
Filters
Showing results (41-50 of 125) with videos related to
Page
of 13
Sort By:
JAMA
|
January 5, 2002
Quinolones and false-positive urine screening for opiates by immunoassay technology
L R Baden, G Horowitz, H Jacoby, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1984
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates
G M Eliopoulos, A Gardella, P DeGirolami, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1987
In vitro activity of BMY-28100, a new oral cephalosporin
G M Eliopoulos, E Reiszner, C Wennersten, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam
Y Carmeli, J Castro, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy
|
May 29, 1999
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents
Y Carmeli, N Troillet, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1985
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic
G M Eliopoulos, C Thauvin, B Gerson, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus
A Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1989
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates
G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 1992
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci
E Cercenado, G M Eliopoulos, C B Wennersten, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1993
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis
A Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 125) with videos related to
Sort By:
Page
of 13
JAMA
|
January 5, 2002
Quinolones and false-positive urine screening for opiates by immunoassay technology
L R Baden, G Horowitz, H Jacoby, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1984
In vitro activity of U-63196E, a new cephalosporin, against clinical bacterial isolates
G M Eliopoulos, A Gardella, P DeGirolami, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1987
In vitro activity of BMY-28100, a new oral cephalosporin
G M Eliopoulos, E Reiszner, C Wennersten, et al.
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Clinical isolation and resistance patterns of and superinfection with 10 nosocomial pathogens after treatment with ceftriaxone versus ampicillin-sulbactam
Y Carmeli, J Castro, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy
|
May 29, 1999
Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents
Y Carmeli, N Troillet, G M Eliopoulos, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1985
In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic
G M Eliopoulos, C Thauvin, B Gerson, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1993
Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus
A Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
|
July 1, 1989
In vitro activity of cefoperazone-sulbactam combinations against cefoperazone-resistant clinical bacterial isolates
G M Eliopoulos, K Klimm, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy
|
October 11, 1992
Absence of synergistic activity between ampicillin and vancomycin against highly vancomycin-resistant enterococci
E Cercenado, G M Eliopoulos, C B Wennersten, et al.
The Journal of Antimicrobial Chemotherapy
|
August 1, 1993
Efficacy of ceftriaxone plus tazobactam in a rat model of intraabdominal abscess due to Bacteroides fragilis
A Pefanis, C Thauvin-Eliopoulos, G M Eliopoulos, et al.
Page
of 13